Search results
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 5 days agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
S&P 500 Gains and Losses Today: Norwegian Cruise Soars on Guidance, Strategy Update
Investopedia· 20 hours agoIn the days ahead, quarterly results from semiconductor giant Nvidia (NVDA) could provide a gauge of...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 7 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
Arbutus urged to halt share issuances amid patent disputes By Investing.com
Investing.com· 3 days ago(NASDAQ: NASDAQ:ABUS), has publicly urged the biopharmaceutical company to stop issuing shares to...
Stocks, Gold Reach New Record Highs, Cruise Stocks Rally, GameStop Sinks: What's Driving Markets...
Benzinga· 8 hours agoWall Street rallies on Monday as major US indices reach fresh record highs. Metal commodities surge,...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 5 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Post-pandemic problems: These stocks are still down more than 50 percent from their Covid highs
Bankrate via Yahoo Finance· 5 days agoIts shares traded as low as $3.55 in December 2022. Covid high stock price: $376.83 Current stock...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 2 days agoNovavax is pursuing full approval for Nuvaxovid in the U.S. It will likely earn the nod, but how...
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Zacks via Yahoo Finance· 4 days agoFulcrum and Sanofi will equally share future global development costs. FULC retains full...